EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 342 filers reported holding EXELIXIS INC in Q2 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,336,605 | -10.2% | 59,484 | -5.2% | 0.01% | -12.5% |
| Q1 2024 | $1,489,129 | -5.0% | 62,753 | -3.9% | 0.02% | -15.8% |
| Q4 2023 | $1,566,979 | +4.3% | 65,318 | -5.0% | 0.02% | -5.0% |
| Q3 2023 | $1,502,668 | +12.8% | 68,772 | -1.4% | 0.02% | +11.1% |
| Q2 2023 | $1,332,655 | -3.5% | 69,736 | -2.0% | 0.02% | -10.0% |
| Q1 2023 | $1,380,905 | +21.9% | 71,144 | +0.7% | 0.02% | +11.1% |
| Q4 2022 | $1,132,777 | +11.8% | 70,622 | +9.3% | 0.02% | -5.3% |
| Q3 2022 | $1,013,000 | -25.2% | 64,612 | -0.7% | 0.02% | -29.6% |
| Q2 2022 | $1,355,000 | -2.7% | 65,095 | +5.9% | 0.03% | +17.4% |
| Q1 2022 | $1,393,000 | +21.9% | 61,457 | -1.7% | 0.02% | +27.8% |
| Q4 2021 | $1,143,000 | -13.0% | 62,510 | +0.6% | 0.02% | -28.0% |
| Q3 2021 | $1,314,000 | +13.8% | 62,151 | -1.9% | 0.02% | +19.0% |
| Q2 2021 | $1,155,000 | +15.8% | 63,379 | +43.6% | 0.02% | 0.0% |
| Q1 2021 | $997,000 | +12.8% | 44,150 | +0.3% | 0.02% | +10.5% |
| Q4 2020 | $884,000 | -17.3% | 44,021 | +0.7% | 0.02% | -26.9% |
| Q3 2020 | $1,069,000 | +15.9% | 43,717 | +12.6% | 0.03% | +8.3% |
| Q2 2020 | $922,000 | – | 38,833 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
| GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
| Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
| CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
| EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
| CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
| Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
| Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |